151 related articles for article (PubMed ID: 11771444)
1. Surgery, radio- and chemotherapy for multimodal treatment of rectal cancer.
Link KH; Staib L; Kornmann M; Formentini A; Schatz M; Suhr P; Messer P; Röttinger E; Beger HG;
Swiss Surg; 2001; 7(6):256-74. PubMed ID: 11771444
[TBL] [Abstract][Full Text] [Related]
2. Multimodal therapy in rectal cancer.
Link KH; Staib L; Schatz M; Suhr P; Röttinger E; Beger HG
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2167-92. PubMed ID: 9881074
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant radiochemotherapy--what is the patients benefit?
Link KH; Staib L; Schatz M; Suhr P; Röttinger E; Beger HG
Langenbecks Arch Surg; 1998 Dec; 383(6):416-26. PubMed ID: 9921941
[TBL] [Abstract][Full Text] [Related]
4. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
5. [Rectal cancer: current status of multimodal therapy--when and how?].
Gaedcke J; Liersch T; Hess C; Becker H; Rödel C; Ghadimi BM
Zentralbl Chir; 2011 Aug; 136(4):334-42. PubMed ID: 21863511
[TBL] [Abstract][Full Text] [Related]
6. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94).
Sauer R; Fietkau R; Wittekind C; Martus P; Rödel C; Hohenberger W; Jatzko G; Sabitzer H; Karstens JH; Becker H; Hess C; Raab R
Strahlenther Onkol; 2001 Apr; 177(4):173-81. PubMed ID: 11370551
[TBL] [Abstract][Full Text] [Related]
8. New aspects of adjuvant radiotherapy in primarily resectable rectal cancer.
Budach W
Onkologie; 2002 Jun; 25(3):223-30. PubMed ID: 12119456
[TBL] [Abstract][Full Text] [Related]
9. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
10. Resection and radiochemotherapy of pancreatic cancer--the future?
Link KH; Formentini A; Leder G; Fortnagel G; Sartori N; Schatz M; Beger HG
Langenbecks Arch Surg; 1998 Apr; 383(2):134-44. PubMed ID: 9641886
[TBL] [Abstract][Full Text] [Related]
11. [Adjuvant and neoadjuvant radiochemotherapy of rectal carcinoma].
Sauer R; Rödel C
Praxis (Bern 1994); 2002 Sep; 91(37):1476-84. PubMed ID: 12360683
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant radiotherapy and radiochemotherapy for rectal cancer.
Rödel C; Sauer R
Recent Results Cancer Res; 2005; 165():221-30. PubMed ID: 15865037
[TBL] [Abstract][Full Text] [Related]
13. A systematic overview of radiation therapy effects in rectal cancer.
Glimelius B; Grönberg H; Järhult J; Wallgren A; Cavallin-Ståhl E
Acta Oncol; 2003; 42(5-6):476-92. PubMed ID: 14596508
[TBL] [Abstract][Full Text] [Related]
14. [Adjuvant and neoadjuvant therapy of rectal carcinoma. The current status].
Rödel C; Hohenberger W; Sauer R
Strahlenther Onkol; 1998 Oct; 174(10):497-504. PubMed ID: 9810316
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of rectal cancer].
Rödel C; Bruch HP; Hofheinz R; Lang H; Arnold D
Onkologie; 2010; 33 Suppl 4():19-23. PubMed ID: 20431308
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
17. Role of combined-modality therapy in the management of locally advanced rectal cancer.
Hosein PJ; Rocha-Lima CM
Clin Colorectal Cancer; 2008 Nov; 7(6):369-75. PubMed ID: 19036689
[TBL] [Abstract][Full Text] [Related]
18. The postoperative adjuvant radiation therapy and radiochemotherapy for UICC stage II and III rectal cancer. A retrospective analysis.
Bagatzounis A; Willner J; Oppitz U; Flentje M
Strahlenther Onkol; 2000 Mar; 176(3):112-7. PubMed ID: 10742831
[TBL] [Abstract][Full Text] [Related]
19. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
20. Impact of adjuvant chemotherapy after neoadjuvant radio- or radiochemotherapy for patients with locally advanced rectal cancer.
Lichthardt S; Zenorini L; Wagner J; Baur J; Kerscher A; Matthes N; Kastner C; Pelz J; Kunzmann V; Germer CT; Wiegering A
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2363-2373. PubMed ID: 28756493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
